Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.4%

169 terminated/withdrawn out of 1029 trials

Success Rate

76.7%

-9.8% vs industry average

Late-Stage Pipeline

11%

116 trials in Phase 3/4

Results Transparency

45%

248 of 555 completed trials have results

Key Signals

184 recruiting248 with results97 terminated72 withdrawn

Enrollment Performance

Analytics

N/A

570(65.4%)

Phase 2

116(13.3%)

Phase 4

82(9.4%)

Phase 1

62(7.1%)

Phase 3

34(3.9%)

Early Phase 1

7(0.8%)

871Total

N/A(570)

Phase 2(116)

Phase 4(82)

Phase 1(62)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1029)

Showing 20 of 1029 trials

NCT07314788Not ApplicableEnrolling By Invitation

Empathy and Virtual Reality (VR)

Role: lead

NCT00001355Recruiting

Detection and Characterization of Host Defense Defects

Role: collaborator

NCT07436637Not ApplicableNot Yet Recruiting

Guardant Shield Colorectal Cancer Screening

Role: lead

NCT07324954Phase 1Recruiting

Methylene Blue in Total Knee Arthroplasty (TKA)

Role: lead

NCT06160986Not ApplicableActive Not Recruiting

Horizons Chronic Graft-Versus-Host-Disease Study

Role: lead

NCT05522569Unknown

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

Role: lead

NCT07469592Not ApplicableNot Yet Recruiting

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

Role: lead

NCT03113994Phase 2Terminated

Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

Role: collaborator

NCT07486869Phase 2Not Yet Recruiting

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

Role: lead

NCT06261346Not ApplicableRecruiting

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

Role: lead

NCT05361694Recruiting

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

Role: lead

NCT07518888Not ApplicableNot Yet Recruiting

Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer

Role: lead

NCT06801795Not ApplicableRecruiting

Aviclear for Hidradenitis Suppurativa (HS)

Role: lead

NCT06801717Not ApplicableRecruiting

Rosacea Radiofrequency Microneedling

Role: lead

NCT06077071Not ApplicableNot Yet Recruiting

MRIdian "RADAR" Trial

Role: lead

NCT00018044Recruiting

Study of Mycobacterial Infections

Role: collaborator

NCT07502352Not ApplicableNot Yet Recruiting

Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)

Role: lead

NCT04685616Phase 3Recruiting

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Role: collaborator

NCT06774079Phase 4Recruiting

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Role: lead

NCT07501065Phase 4Not Yet Recruiting

Prophylactic Antibiotics for Outpatient Urethral Bulking

Role: lead